Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hormone-sensitive lipase (HSL) is a key intracellular enzyme involved in lipid metabolism. It primarily catalyzes the hydrolysis of stored triglycerides, diglycerides, and monoglycerides within adipocytes and other tissues, releasing free fatty acids and glycerol. HSL also acts on cholesteryl esters and retinyl esters, contributing to cholesterol mobilization and vitamin A metabolism. HSL activity is tightly regulated by hormonal signals like catecholamines (activation) and insulin (inhibition), and its dysregulation is implicated in metabolic disorders such as obesity and type 2 diabetes.
Drugs inhibit HSL activity to reduce free fatty acid release and improve insulin sensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hormone-Sensitive Lipase (HSL).